Quick Answer
HEALTHSTREAM INC reported Research And Development Expense of $50.98 million for the year ending 2025.
- HEALTHSTREAM INC showed an increase of +4.3% in Research And Development Expense from 2024 to 2025.
- This data is from HEALTHSTREAM INC's annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $1.72 million | Q3 2010: $1.75 million | Q1 2011: $1.79 million | Q2 2011: $1.91 million | Q3 2011: $1.95 million | Q1 2012: $1.87 million | Q2 2012: $2.18 million | Q3 2012: $2.28 million | Q1 2013: $2.61 million | Q2 2013: $2.78 million | Q3 2013: $3.21 million | Q1 2014: $3.55 million | Q2 2014: $4.29 million | Q3 2014: $4.21 million | Q1 2015: $4.65 million | Q2 2015: $5.82 million | Q3 2015: $6.20 million | Q1 2016: $7.02 million | Q2 2016: $7.24 million | Q3 2016: $7.26 million | Q1 2017: $5.78 million | Q2 2017: $6.15 million | Q3 2017: $6.00 million | Q1 2018: $6.00 million | Q2 2018: $6.55 million | Q3 2018: $6.60 million | Q1 2019: $6.93 million | Q2 2019: $7.64 million | Q3 2019: $7.20 million | Q1 2020: $7.47 million | Q2 2020: $7.83 million | Q3 2020: $8.19 million | Q1 2021: $9.53 million | Q2 2021: $10.34 million | Q3 2021: $10.34 million | Q1 2022: $10.41 million | Q2 2022: $10.58 million | Q3 2022: $11.48 million | Q1 2023: $11.68 million | Q2 2023: $11.03 million | Q3 2023: $10.90 million | Q1 2024: $12.03 million | Q2 2024: $12.08 million | Q3 2024: $12.10 million | Q1 2025: $12.05 million | Q2 2025: $12.07 million | Q3 2025: $12.11 million.
- Over the full 17 years of available data (2009 to 2025), HEALTHSTREAM INC's Research And Development Expense has grown by 711.2%.
- Historical annual values: Fiscal year 2025: $50.98 million | Fiscal year 2024: $48.89 million | Fiscal year 2023: $45.54 million | Fiscal year 2022: $44.28 million | Fiscal year 2021: $41.66 million | Fiscal year 2020: $32.31 million | Fiscal year 2019: $29.11 million | Fiscal year 2018: $25.74 million | Fiscal year 2017: $24.15 million | Fiscal year 2016: $24.23 million | Fiscal year 2015: $24.21 million | Fiscal year 2014: $16.46 million | Fiscal year 2013: $11.76 million | Fiscal year 2012: $8.61 million | Fiscal year 2011: $7.47 million | Fiscal year 2010: $6.99 million | Fiscal year 2009: $6.29 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: